New Covenant Trust Company’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-230
Closed -$31.7K 299
2024
Q1
$31.7K Buy
+230
New +$31.7K 0.03% 202